Bias Source of Signal in SCOUT DS

Stopped early

Conditions studied: Type 2 Diabetes

In brief

The primary objective is to identify device characteristics, components or subsystems that manifest as screening score bias in SCOUT DS.

Key facts

Study ID

NCT01550328

Run by

VeraLight, Inc.

People needed

25

Starts

2012-04-01

Expected to finish

2013-01-01

Last updated by the study team

2013-01-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males and/ or females greater than or equal to 18 years of age

You may not qualify if…

• Have received investigational treatments in the past 14 days
• Have psychosocial issues that interfere with an ability to follow study procedures
• Are known to be pregnant
• Have scars, tattoos, rashes or other disruption/discoloration on the left volar forearm.
• Have been treated in the past month with oral steroid therapy or topical steroids applied to the left forearm. Inhaled steroid therapy is not a basis for exclusion
• Are receiving medications that fluoresce (A list of excluded medications is located in Appendix H)
• Are known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to ultraviolet light, or taking medication known to cause photosensitivity)

Where it is running

• VeraLight — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.